A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Prurigo nodularis

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin A Study of CDX-0159 in Patients With Prurigo Nodularis Expanded Access Use of Dupilumab Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis Safety and Efficacy of Nemolizumab in PN Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) Pain Outcomes Following Intralesional Corticosteroid Injections A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis PRISM Study-Pruritus Relief Through Itch Scratch Modulation Safety and Efficacy of CC-10004 for Prurigo Nodularis Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)